Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders

Monoamine oxidase B (MAO B) is a mitochondrial outermembrane flavoenzyme that is a well-known target for antidepressant and neuroprotective drugs. We determined the structure of the human enzyme to 3 Å resolution. The enzyme binds to the membrane through a C-terminal transmembrane helix and apolar loops located at various positions in the sequence. The electron density shows that pargyline, an analog of the clinically used MAO B inhibitor, deprenyl, binds covalently to the flavin N5 atom. The active site of MAO B consists of a 420 Å3-hydrophobic substrate cavity interconnected to an entrance cavity of 290 Å3. The recognition site for the substrate amino group is an aromatic cage formed by Tyr 398 and Tyr 435. The structure provides a framework for probing the catalytic mechanism, understanding the differences between the B- and A-monoamine oxidase isoforms and designing specific inhibitors.

[1]  M. Sansom,et al.  Amino acid distributions in integral membrane protein structures. , 2001, Biochimica et biophysica acta.

[2]  G. B. Zavoico,et al.  Cytoplasmic Ca2+ in platelets is controlled by cyclic AMP: antagonism between stimulators and inhibitors of adenylate cyclase. , 1984, Biochemical and biophysical research communications.

[3]  G. Heijne.  Membrane protein structure prediction. Hydrophobicity analysis and the positive-inside rule. , 1992, Journal of molecular biology.

[4]  J. Navaza,et al.  AMoRe: an automated package for molecular replacement , 1994 .

[5]  P. Kraulis.  A program to produce both detailed and schematic plots of protein structures , 1991 .

[6]  K. Chiba,et al.  Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. , 1984, Biochemical and biophysical research communications.

[7]  D. Edmondson,et al.  Structure-activity relationships in the oxidation of benzylamine analogues by bovine liver mitochondrial monoamine oxidase B. , 1994, Biochemistry.

[8]  M. Fraaije,et al.  Flavoenzymes: diverse catalysts with recurrent features. , 2000, Trends in biochemical sciences.

[9]  D. Edmondson,et al.  Structure-activity relationships in the oxidation of para-substituted benzylamine analogues by recombinant human liver monoamine oxidase A. , 1999, Biochemistry.

[10]  J. Shih,et al.  Effects of Carboxyl-terminal Truncations on the Activity and Solubility of Human Monoamine Oxidase B* , 2001, The Journal of Biological Chemistry.

[11]  R. Schroeder,et al.  Modulation of RNA function by aminoglycoside antibiotics , 2000, The EMBO journal.

[12]  A. Parini,et al.  Monoamine oxidase B induces ERK-dependent cell mitogenesis by hydrogen peroxide generation. , 2000, Biochemical and biophysical research communications.

[13]  J. Shih,et al.  Substrate and Inhibitor Specificities for Human Monoamine Oxidase A and B Are Influenced by a Single Amino Acid* , 2001, The Journal of Biological Chemistry.

[14]  M. Sutcliffe,et al.  Structural and biochemical characterization of recombinant wild type and a C30A mutant of trimethylamine dehydrogenase from methylophilus methylotrophus (sp. W(3)A(1)). , 1999, Biochemistry.

[15]  D. Goldstein,et al.  Catecholamines : bridging basic science with clinical medicine , 1998 .

[16]  D. Edmondson,et al.  High-level expression of human liver monoamine oxidase B in Pichia pastoris. , 2000, Protein expression and purification.

[17]  R M Esnouf,et al.  Further additions to MolScript version 1.4, including reading and contouring of electron-density maps. , 1999, Acta crystallographica. Section D, Biological crystallography.

[18]  K Cowtan,et al.  Miscellaneous algorithms for density modification. , 1998, Acta crystallographica. Section D, Biological crystallography.

[19]  G J Kleywegt,et al.  Detection, delineation, measurement and display of cavities in macromolecular structures. , 1994, Acta crystallographica. Section D, Biological crystallography.

[20]  J. Shih,et al.  Site-directed mutagenesis of monoamine oxidase A and B: role of cysteines. , 1993, Molecular pharmacology.

[21]  C. Sander,et al.  Protein structure comparison by alignment of distance matrices. , 1993, Journal of molecular biology.

[22]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[23]  Suzanne Fortier,et al.  Direct methods for solving macromolecular structures , 1998 .

[24]  Liang Tong,et al.  [34] Rotation function calculations with GLRF program. , 1997, Methods in enzymology.

[25]  Paolo Ascenzi,et al.  A 30 Å long U-shaped catalytic tunnel in the crystal structure of polyamine oxidase , 1999 .

[26]  N. Volkow,et al.  Inhibition of monoamine oxidase B in the brains of smokers , 1996, Nature.

[27]  A. Ito,et al.  Mitochondrial targeting signal of rat liver monoamine oxidase B is located at its carboxy terminus. , 1992, Journal of biochemistry.

[28]  V. Chan‐Palay,et al.  Increased monoamine oxidase b activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography , 1994, Neuroscience.

[29]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[30]  R. Coulombe,et al.  The structure of L‐amino acid oxidase reveals the substrate trajectory into an enantiomerically conserved active site , 2000, The EMBO journal.

[31]  G. Murshudov,et al.  Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.